Mineralys Therapeutics, Inc. (MLYS)

Last Year

11-May-23 -- 10-May-24

Time Period:

$7.53M Net Amount

Buy:	$7.53M	$12.89 - $13.50
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

4

0

3

+1

0

+2

1

+3

Two Year Chart

11-May-22 -- 10-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Apr-24 4:24 PM View:	12-Apr-24 Option Exercise $6.86K	Rodman David Malcom Chief Medical Officer		Mineralys Therapeutics, Inc. - MLYS	100% 0 to 67.0K	0	0	--	--	Show Txns Hide Txns

27-Nov-23 4:01 PM View:	22-Nov-23 Private Purchase $25.36K	Congleton Jon Chief Executive Officer Director		Mineralys Therapeutics, Inc. - MLYS	1% 1.04M to 1.05M	$25.78K	0	$12.89	--	Show Txns Hide Txns

14-Feb-24 9:07 PM View:	12-Feb-24 Grant $7.50M	Akkaraju Srinivas Director 10% Owner		Mineralys Therapeutics, Inc. - MLYS	12% 4.52M to 5.07M	0	0	--	--	Show Txns Hide Txns

14-Feb-24 7:49 PM View:	12-Feb-24 Grant $22.58M	Ra Capital Management, LLC Director		Mineralys Therapeutics, Inc. - MLYS	53% 3.18M to 4.85M	0	0	--	--	Show Txns Hide Txns

14-Feb-24 9:06 PM View:	12-Feb-24 Market Purchase $7.50M	Samsara Biocapital Gp, LLC 10% Owner		Mineralys Therapeutics, Inc. - MLYS	12% 4.52M to 5.07M	$7.50M 12%	0	$13.50	--	Show Txns Hide Txns